» Articles » PMID: 18596256

Regulation of Integrin Activation Through the B-cell Receptor

Overview
Journal J Cell Sci
Specialty Cell Biology
Date 2008 Jul 4
PMID 18596256
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Effective immune surveillance is absolutely dependent on the migration of lymphocytes throughout the body and on their successful recognition of specific antigens. Both of these functions rely on the capacity of integrins that are expressed on the surface of lymphocytes to respond in a highly regulated manner to a variety of chemokines and antigens. This Commentary is primarily concerned with the role of the B-cell integrins LFA-1 and VLA-4 in the antigen-recognition process, and summarises what is currently known about the molecular mechanisms of ;inside-out' integrin activation in response to B-cell-receptor stimulation. Recent investigations have identified Vav, PI3K and small GTPases as crucial regulators of the inside-out activation of B-cell integrins. These observations are of particular interest as they allude to an underlying mechanism by which B-cell-receptor-mediated signalling is linked to cytoskeleton reorganisation and subsequent integrin activation.

Citing Articles

Evaluation of Constitutive or Induced Activation State of the VLA-4 Integrin in Human and Murine Samples.

Tissino E, Zucchetto A, Pozzo F, Hartmann T, Gattei V Methods Mol Biol. 2025; 2909:45-60.

PMID: 40029514 DOI: 10.1007/978-1-0716-4442-3_4.


The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands.

Tissino E, Gaglio A, Nicolo A, Pozzo F, Bittolo T, Rossi F Leukemia. 2024; 38(10):2127-2140.

PMID: 39143370 PMC: 11436378. DOI: 10.1038/s41375-024-02376-7.


Novel and Mutations Associated with Leukocyte Adhesion Deficiency-III and Sensorineural Hearing Loss.

Candelaria G, Antunes A, Pastorino A, Dorna M, Zanardo E, Dias A J Pediatr Genet. 2024; 12(4):348-351.

PMID: 38162163 PMC: 10756723. DOI: 10.1055/s-0041-1733948.


Deciphering the role of DOCK8 in tumorigenesis by regulating immunity and the application of nanotechnology in DOCK8 deficiency therapy.

Zhang L, Cao Y, Dai X, Zhang X Front Pharmacol. 2022; 13:1065029.

PMID: 36386145 PMC: 9664064. DOI: 10.3389/fphar.2022.1065029.


Trans-Endothelial Migration of Memory T Cells Is Impaired in Alemtuzumab-Treated Multiple Sclerosis Patients.

Nguyen K, Juillard P, Hawke S, Grau G, Marsh-Wakefield F J Clin Med. 2022; 11(21).

PMID: 36362494 PMC: 9658536. DOI: 10.3390/jcm11216266.